GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
99 hedge funds and large institutions have $664M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
23% less capital invested
Capital invested by funds: $863M → $664M (-$199M)
87% less call options, than puts
Call options by funds: $640K | Put options by funds: $5.01M
Holders
99
Holding in Top 10
1
Calls
$640K
Puts
$5.01M
Top Buyers
| 1 | +$9.04M | |
| 2 | +$6.89M | |
| 3 | +$5.95M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.73M |
| 5 |
Millennium Management
New York
|
+$3.6M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$5.81M | |
| 3 | -$4.28M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4.19M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$3.07M |